
Ravi B. Parikh
Advanced Illness
Cancer Care Delivery
Human-Machine Collaboration
Technology will transform how we deliver care in cancer and advanced illness
I am an oncologist and a researcher.
I see patients with prostate and bladder cancer at Emory University and Winship Cancer Institute, where I am Associate Professor.
I lead the Human-Algorithm Collaboration Lab, a research group that studies questions in advanced illness care and policy using real-world data, machine learning, and clinical trials. Our trials test population-level interventions based on analytics, behavioral economics, and digital health.
I advise nonprofits, health systems, and early-stage to Fortune 500 companies on these topics.
Latest writing
Daily, I see posts from doctors railing on insurance companies about prior authorization hurting their patients. But when payers are the only agent incentivized to lower costs, prior authorization results. Let's stop shouting at the wind and instead put some teeth behind cost-conscious care efforts.
Latest research
One of the hardest things I do in clinic is translate results from a clinical trial to the patient in front of me. In Nature Medicine, we introduce TrialTranslator, a machine learning framework for individualized cancer trial emulation.
Latest media
Check out this CBS News and Kaiser Family Foundation study on the monitoring required for health AI and how many systems aren't meeting the moment. It features quotes by me and our paper on algorithmic drift in a clinical risk prediction model.
What people are saying
“Dr. Parikh has been instrumental in helping us leverage and interpret real-world data and to develop and implement novel solutions to accelerate value-based oncology.”
“Dr Parikh’s approach to any technical issue - metric development, quality improvement, bedside care - is to start with the individual facing serious illness and their community. In our experience this mindset is all too often espoused but rarely practiced day in and day out. We are fortunate to have Dr. Parikh’s leadership in identifying and testing practical interventions that can lead to systemic, public policy and other reforms needed in ensuring high quality care for those with serious illness — especially those who are under-resourced and underserved.”
Latest social media
Affiliations
